The Novel Coronavirus 2019 epidemic and kidneys.
作者信息
Naicker Saraladevi, Yang Chih-Wei, Hwang Shang-Jyh, Liu Bi-Cheng, Chen Jiang-Hua, Jha Vivekanand
机构信息
Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Nephrology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
出版信息
Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7.
Abstract
摘要
相似文献
1
The Novel Coronavirus 2019 epidemic and kidneys.2019新型冠状病毒疫情与肾脏
Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7.
2
Kidney diseases in the time of COVID-19: major challenges to patient care.新冠疫情时期的肾脏疾病：患者护理面临的重大挑战
J Clin Invest. 2020 Jun 1;130(6):2749-2751. doi: 10.1172/JCI138871.
3
Toward understanding the 2019 Coronavirus and its impact on the heart.迈向了解2019冠状病毒及其对心脏的影响。
J Thromb Thrombolysis. 2020 Jul;50(1):33-42. doi: 10.1007/s11239-020-02107-6.
4
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.新冠患者肾脏替代治疗即将面临短缺
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):880-882. doi: 10.2215/CJN.05180420. Epub 2020 Apr 28.
5
Acute Kidney Injury in COVID-19: Another Challenge for Nephrology.新型冠状病毒肺炎相关急性肾损伤：肾脏病学面临的又一挑战
Am J Nephrol. 2020;51(10):761-763. doi: 10.1159/000511161. Epub 2020 Oct 15.
6
COVID-19 and the kidney.新型冠状病毒肺炎与肾脏。
Cleve Clin J Med. 2020 Oct 1;87(10):619-631. doi: 10.3949/ccjm.87a.20072.
7
COVID-19 and Kidney Injury.新型冠状病毒肺炎与肾损伤
R I Med J (2013). 2020 Sep 4;103(8):24-28.
8
[What I talk about when I talk about COVID-19].当我谈论新冠病毒时我在谈些什么
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
9
Hypotension, Systemic Inflammatory Response Syndrome, and COVID-19: A Clinical Conundrum.低血压、全身炎症反应综合征与新型冠状病毒肺炎：一个临床难题。
Anesth Analg. 2020 Sep;131(3):e175-e176. doi: 10.1213/ANE.0000000000005062.
10
We all need a yellow submarine!我们都需要一艘黄色潜水艇！
Prog Cardiovasc Dis. 2020 May-Jun;63(3):389. doi: 10.1016/j.pcad.2020.04.001. Epub 2020 Apr 1.
引用本文的文献
1
The Cerebral Haemorrhage and SARS-CoV-2: An Emerging Virus From a Meta-Analysis Perspective.脑出血与新型冠状病毒肺炎：基于荟萃分析视角的一种新兴病毒
Rev Med Virol. 2025 Sep;35(5):e70069. doi: 10.1002/rmv.70069.
2
Estimated glomerular filtration rate in post COVID-19 patients at 3-6 months and 12-18 months after infection.新冠感染后3至6个月及12至18个月的新冠康复患者的估计肾小球滤过率
Ren Fail. 2025 Dec;47(1):2551737. doi: 10.1080/0886022X.2025.2551737. Epub 2025 Sep 2.
3
COVID-19 Infection Induces Rhabdomyolysis and Acute Kidney Injury.新型冠状病毒肺炎感染可导致横纹肌溶解和急性肾损伤。
Cureus. 2025 Aug 28;17(8):e91153. doi: 10.7759/cureus.91153. eCollection 2025 Aug.
4
Optimal control analysis to reduce the health complexity of co-infection with COVID-19 and kidney disease.优化控制分析以降低新冠病毒与肾脏疾病合并感染的健康复杂性。
Sci Rep. 2025 Jul 2;15(1):22845. doi: 10.1038/s41598-025-05755-x.
5
Prevalence of Acute Renal Failure, Para-Clinical Outcomes, and Mortality in COVID-19 Patients.新型冠状病毒肺炎患者急性肾衰竭的患病率、亚临床结局及死亡率
Clin Med Res. 2024 Dec;22(4):188-196. doi: 10.3121/cmr.2024.1955.
6
Upregulation of the MAP2K4 gene triggers endothelial-mesenchymal transition in COVID-19.MAP2K4基因的上调引发了新冠肺炎中的内皮-间充质转化。
Mol Biol Rep. 2025 Jan 31;52(1):180. doi: 10.1007/s11033-025-10289-6.
7
Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data.基础疾病及并发症对韩国新冠疫情死亡率的影响：基于国民健康保险服务数据的分析
Arch Public Health. 2025 Jan 23;83(1):20. doi: 10.1186/s13690-025-01509-3.
8
Kidney failure-related excess mortality during the first three years of the COVID-19 pandemic in the United States: a nation-wide, population-based analysis.美国新冠疫情头三年与肾衰竭相关的额外死亡率：一项基于全国人口的分析。
BMC Public Health. 2025 Jan 17;25(1):210. doi: 10.1186/s12889-025-21422-2.
9
Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19.严重 COVID-19 患者住院病死率的危险因素病例对照研究。
Front Public Health. 2024 Oct 8;12:1424720. doi: 10.3389/fpubh.2024.1424720. eCollection 2024.
10
SARS-CoV-2 infection causes a decline in renal megalin expression and affects vitamin D metabolism in the kidney of K18-hACE2 mice.SARS-CoV-2 感染导致 K18-hACE2 小鼠肾脏中的 megalin 表达下降，并影响肾脏中的维生素 D 代谢。
Sci Rep. 2024 Oct 16;14(1):24313. doi: 10.1038/s41598-024-75338-9.
本文引用的文献
1
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
2
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex.利用合成肽表位-CpG-DNA-脂质体复合物生成并鉴定针对 MERS-CoV 刺突蛋白的单克隆抗体。
BMB Rep. 2019 Jun;52(6):397-402. doi: 10.5483/BMBRep.2019.52.6.185.
7
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
8
Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.中东呼吸综合征冠状病毒感染危重症患者的临床过程和结局。
Ann Intern Med. 2014 Mar 18;160(6):389-97. doi: 10.7326/M13-2486.
9
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.二肽基肽酶 4 是新兴的人类冠状病毒-EMC 的功能性受体。
Nature. 2013 Mar 14;495(7440):251-4. doi: 10.1038/nature12005.
10
Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.接受高容量血液滤过和持续静静脉血液滤过的脓毒症患者血清白细胞介素-6和白细胞介素-1受体拮抗剂与序贯器官衰竭评估评分的关系
Nephrology (Carlton). 2006 Oct;11(5):386-93. doi: 10.1111/j.1440-1797.2006.00600.x.
Zotero 插件